End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,350 KRW | -0.68% | +0.68% | +33.64% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Radiopharmaceuticals
95.9
%
| 30,929 | 95.4 % | 33,281 | 95.9 % | +7.60% |
Medical Equipment Lease
4.1
%
| 1,493 | 4.6 % | 1,415 | 4.1 % | -5.27% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
99.7
%
| 32,392 | 99.9 % | 34,592 | 99.7 % | +6.79% |
North America
0.2
%
| - | - | 60 | 0.2 % | - |
Asia
0.1
%
| 19 | 0.1 % | 31 | 0.1 % | +57.89% |
Europe
0.0
%
| 11 | 0.0 % | 13 | 0.0 % | +19.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jong-Woo Kim
CEO | Chief Executive Officer | 56 | 02-11-05 |
Jae-Ki Park
PSD | President | 70 | 13-04-30 |
Hyun-Joon Ha
CTO | Chief Tech/Sci/R&D Officer | 65 | - |
Bong-Seok Kim
PRN | Corporate Officer/Principal | 58 | 11-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gyeong-Ho Lee
BRD | Director/Board Member | 74 | 22-03-28 |
Jong-Woo Kim
CEO | Chief Executive Officer | 56 | 02-11-05 |
Bong-Seok Kim
PRN | Corporate Officer/Principal | 58 | 11-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,025,220 | 9,563,965 ( 35.39 %) | 273,787 ( 1.013 %) | 35.39 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DUCHEMBIO CO.,LTD. 1.01% | 273,787 | 1.01% | 1,403,254 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+33.64% | 144M | |
+25.83% | 661B | |
+26.53% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.81% | 231B | |
+5.28% | 200B | |
-8.88% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- A176750 Stock
- Company DuChemBIO Co.,Ltd.